TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 1 | -7 | 9 | 22 | 50 | -33 | 7 |
| P | %wins | 100 | 0 | 100 | 100 | 100 | 0 | 67 | |||
| S | %ret | 1 | 1 | 4 | -3 | -2 | -13 | 13 | 18 | -6 | 1 |
| S | %wins | 75 | 100 | 100 | 25 | 25 | 50 | 63 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/22/14 18:26 | 12/18/14 | RIGL | Rigel Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Vance Dolly | CA | O | EVP Corp | S.a | -2 | 2.22 | 2 | -1 | -63 | 1 | D | -62 | 1 | -38 | 14 | 37 | 10 | 2 | 15 | -7 | -2 | -11 | 36 | 43 | 45 |
12/19/14 18:56 | 12/18/14 | RIGL | Rigel Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Vance Dolly | CA | O | EVP Corp | S | -2 | 2.22 | 1 | -1 | -63 | 1 | D | -64 | 0 | -41 | 8 | 23 | 10 | -1 | 11 | -3 | -6 | -14 | 42 | 43 | 43 |
9/14/12 18:45 | 9/13/12 | RIGL | Rigel Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Vance Dolly | CA | O | EVP Corp | S | -43 | 10.43 | 2 | -4 | -79 | 1 | D | 20 | 38 | 22 | 26 | 1 | 6 | 6 | 2 | -1 | -1 | -11 | -37 | -30 | -66 |
5/10/05 18:17 | 5/10/05 | RIGL | Rigel Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Vance Dolly | CA | O | VP Intel | M.d | 138 | 9.20 | 4 | 15 | 4 | D | 123 | -8 | -24 | 1 | 24 | 27 | 14 | 5 | 1 | 0 | -17 | 9 | 16 | -45 | |
5/10/05 18:17 | 5/10/05 | RIGL | Rigel Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Vance Dolly | CA | O | VP Intel | S.d | -296 | 19.71 | 4 | -15 | -77 | 4 | D | 123 | -8 | -24 | 1 | 24 | 27 | 14 | 5 | 1 | 0 | -17 | 9 | 16 | -45 |
3/30/05 17:41 | 3/30/05 | RIGL | Rigel Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Vance Dolly | CA | O | VP Intel | P | 16 | 15.99 | 5 | 1 | 30 | 4 | D | 124 | -16 | -33 | -35 | -20 | 0 | -2 | -5 | 1 | -7 | 9 | 22 | 50 | -33 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |